Skip to main content
Special Sale: Up to 30% off selected items. Shop Now
Toggle menu
0
  • Home
  • Medical
  • GLYXAMBI Drug Profile, 2024: GLYXAMBI (empagliflozin; linagliptin) drug patents, FDA exclusivity, litigation, drug prices

Independently Published

GLYXAMBI Drug Profile, 2024: GLYXAMBI (empagliflozin; linagliptin) drug patents, FDA exclusivity, litigation, drug prices

No reviews yet
Product Code: 9798875603297
ISBN13: 9798875603297
Condition: New
$249.00
$234.12
Sale 6%
Hurry! Only left
Share:

GLYXAMBI Drug Profile, 2024: GLYXAMBI (empagliflozin; linagliptin) drug patents, FDA exclusivity, litigation, drug prices

$249.00
$234.12
Sale 6%

Write a Review

GLYXAMBI Drug Profile, 2024: GLYXAMBI (empagliflozin; linagliptin) drug patents, FDA exclusivity, litigation, drug prices

Independently Published

GLYXAMBI Drug Profile, 2024: GLYXAMBI (empagliflozin; linagliptin) drug patents, FDA exclusivity, litigation, drug prices


 
GLYXAMBI Drug Profile, 2024

FREE UPDATES: Send your receipt within 30 days for a free PDF update.

This report focuses on GLYXAMBI and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Drug prices
  • Finished product suppliers
FREE UPDATE: Contact DrugPatentWatch with your receipt within 30 days for a free update


Author: Drugpatentwatch
Publisher: Independently Published
Publication Date: Jan 09, 2024
Number of Pages: 142 pages
Binding: Paperback or Softback
ISBN-10: NA
ISBN-13: 9798875603297
 

Customer Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Write a Review

Faster Shipping

Delivery in 3-8 days

Easy Returns

14 days returns

Discount upto 30%

Monthly discount on books

Outstanding Customer Service

Support 24 hours a day